Pharma & Healthcare

Global Gastrointestinal Therapeutics and Diagnostics Market Research Report 2025

This report aims to provide a comprehensive presentation of the global market for Gastrointestinal Therapeutics and Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastrointestinal Therapeutics and Diagnostics.
The Gastrointestinal Therapeutics and Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gastrointestinal Therapeutics and Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gastrointestinal Therapeutics and Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
AstraZeneca
Eisai
Johnson & Johnson
Salix Pharmaceuticals
Takeda Pharmaceutical Company
Segment by Type
Diagnostics
Therapeutics
Segment by Application
Gastroenteritis
GI Bleeding
Irritable Bowel Syndrome
Peptic Ulcer Disease (PUD)
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gastrointestinal Therapeutics and Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Diagnostics
1.2.3 Therapeutics
1.3 Market by Application
1.3.1 Global Gastrointestinal Therapeutics and Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Gastroenteritis
1.3.3 GI Bleeding
1.3.4 Irritable Bowel Syndrome
1.3.5 Peptic Ulcer Disease (PUD)
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gastrointestinal Therapeutics and Diagnostics Market Perspective (2020-2031)
2.2 Global Gastrointestinal Therapeutics and Diagnostics Growth Trends by Region
2.2.1 Global Gastrointestinal Therapeutics and Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Gastrointestinal Therapeutics and Diagnostics Historic Market Size by Region (2020-2025)
2.2.3 Gastrointestinal Therapeutics and Diagnostics Forecasted Market Size by Region (2026-2031)
2.3 Gastrointestinal Therapeutics and Diagnostics Market Dynamics
2.3.1 Gastrointestinal Therapeutics and Diagnostics Industry Trends
2.3.2 Gastrointestinal Therapeutics and Diagnostics Market Drivers
2.3.3 Gastrointestinal Therapeutics and Diagnostics Market Challenges
2.3.4 Gastrointestinal Therapeutics and Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gastrointestinal Therapeutics and Diagnostics Players by Revenue
3.1.1 Global Top Gastrointestinal Therapeutics and Diagnostics Players by Revenue (2020-2025)
3.1.2 Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Players (2020-2025)
3.2 Global Gastrointestinal Therapeutics and Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Gastrointestinal Therapeutics and Diagnostics Revenue
3.4 Global Gastrointestinal Therapeutics and Diagnostics Market Concentration Ratio
3.4.1 Global Gastrointestinal Therapeutics and Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Therapeutics and Diagnostics Revenue in 2024
3.5 Global Key Players of Gastrointestinal Therapeutics and Diagnostics Head office and Area Served
3.6 Global Key Players of Gastrointestinal Therapeutics and Diagnostics, Product and Application
3.7 Global Key Players of Gastrointestinal Therapeutics and Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gastrointestinal Therapeutics and Diagnostics Breakdown Data by Type
4.1 Global Gastrointestinal Therapeutics and Diagnostics Historic Market Size by Type (2020-2025)
4.2 Global Gastrointestinal Therapeutics and Diagnostics Forecasted Market Size by Type (2026-2031)
5 Gastrointestinal Therapeutics and Diagnostics Breakdown Data by Application
5.1 Global Gastrointestinal Therapeutics and Diagnostics Historic Market Size by Application (2020-2025)
5.2 Global Gastrointestinal Therapeutics and Diagnostics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Gastrointestinal Therapeutics and Diagnostics Market Size (2020-2031)
6.2 North America Gastrointestinal Therapeutics and Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2020-2025)
6.4 North America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gastrointestinal Therapeutics and Diagnostics Market Size (2020-2031)
7.2 Europe Gastrointestinal Therapeutics and Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2020-2025)
7.4 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size (2020-2031)
8.2 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2020-2025)
8.4 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gastrointestinal Therapeutics and Diagnostics Market Size (2020-2031)
9.2 Latin America Gastrointestinal Therapeutics and Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2020-2025)
9.4 Latin America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size (2020-2031)
10.2 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2020-2025)
10.4 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Introduction
11.1.4 Abbott Laboratories Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2020-2025)
11.1.5 Abbott Laboratories Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Gastrointestinal Therapeutics and Diagnostics Introduction
11.2.4 AstraZeneca Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2020-2025)
11.2.5 AstraZeneca Recent Development
11.3 Eisai
11.3.1 Eisai Company Details
11.3.2 Eisai Business Overview
11.3.3 Eisai Gastrointestinal Therapeutics and Diagnostics Introduction
11.3.4 Eisai Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2020-2025)
11.3.5 Eisai Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Introduction
11.4.4 Johnson & Johnson Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2020-2025)
11.4.5 Johnson & Johnson Recent Development
11.5 Salix Pharmaceuticals
11.5.1 Salix Pharmaceuticals Company Details
11.5.2 Salix Pharmaceuticals Business Overview
11.5.3 Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Introduction
11.5.4 Salix Pharmaceuticals Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2020-2025)
11.5.5 Salix Pharmaceuticals Recent Development
11.6 Takeda Pharmaceutical Company
11.6.1 Takeda Pharmaceutical Company Company Details
11.6.2 Takeda Pharmaceutical Company Business Overview
11.6.3 Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Introduction
11.6.4 Takeda Pharmaceutical Company Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2020-2025)
11.6.5 Takeda Pharmaceutical Company Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Diagnostics
Table 3. Key Players of Therapeutics
Table 4. Global Gastrointestinal Therapeutics and Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Region (2020-2025)
Table 8. Global Gastrointestinal Therapeutics and Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Region (2026-2031)
Table 10. Gastrointestinal Therapeutics and Diagnostics Market Trends
Table 11. Gastrointestinal Therapeutics and Diagnostics Market Drivers
Table 12. Gastrointestinal Therapeutics and Diagnostics Market Challenges
Table 13. Gastrointestinal Therapeutics and Diagnostics Market Restraints
Table 14. Global Gastrointestinal Therapeutics and Diagnostics Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Players (2020-2025)
Table 16. Global Top Gastrointestinal Therapeutics and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Therapeutics and Diagnostics as of 2024)
Table 17. Ranking of Global Top Gastrointestinal Therapeutics and Diagnostics Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Gastrointestinal Therapeutics and Diagnostics Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Gastrointestinal Therapeutics and Diagnostics, Headquarters and Area Served
Table 20. Global Key Players of Gastrointestinal Therapeutics and Diagnostics, Product and Application
Table 21. Global Key Players of Gastrointestinal Therapeutics and Diagnostics, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Type (2020-2025)
Table 25. Global Gastrointestinal Therapeutics and Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Type (2026-2031)
Table 27. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Application (2020-2025)
Table 29. Global Gastrointestinal Therapeutics and Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Application (2026-2031)
Table 31. North America Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 46. Abbott Laboratories Company Details
Table 47. Abbott Laboratories Business Overview
Table 48. Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Product
Table 49. Abbott Laboratories Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2020-2025) & (US$ Million)
Table 50. Abbott Laboratories Recent Development
Table 51. AstraZeneca Company Details
Table 52. AstraZeneca Business Overview
Table 53. AstraZeneca Gastrointestinal Therapeutics and Diagnostics Product
Table 54. AstraZeneca Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2020-2025) & (US$ Million)
Table 55. AstraZeneca Recent Development
Table 56. Eisai Company Details
Table 57. Eisai Business Overview
Table 58. Eisai Gastrointestinal Therapeutics and Diagnostics Product
Table 59. Eisai Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2020-2025) & (US$ Million)
Table 60. Eisai Recent Development
Table 61. Johnson & Johnson Company Details
Table 62. Johnson & Johnson Business Overview
Table 63. Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Product
Table 64. Johnson & Johnson Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2020-2025) & (US$ Million)
Table 65. Johnson & Johnson Recent Development
Table 66. Salix Pharmaceuticals Company Details
Table 67. Salix Pharmaceuticals Business Overview
Table 68. Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Product
Table 69. Salix Pharmaceuticals Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2020-2025) & (US$ Million)
Table 70. Salix Pharmaceuticals Recent Development
Table 71. Takeda Pharmaceutical Company Company Details
Table 72. Takeda Pharmaceutical Company Business Overview
Table 73. Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Product
Table 74. Takeda Pharmaceutical Company Revenue in Gastrointestinal Therapeutics and Diagnostics Business (2020-2025) & (US$ Million)
Table 75. Takeda Pharmaceutical Company Recent Development
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
Table 79. Authors List of This Report


List of Figures
Figure 1. Gastrointestinal Therapeutics and Diagnostics Picture
Figure 2. Global Gastrointestinal Therapeutics and Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Type: 2024 VS 2031
Figure 4. Diagnostics Features
Figure 5. Therapeutics Features
Figure 6. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Application: 2024 VS 2031
Figure 8. Gastroenteritis Case Studies
Figure 9. GI Bleeding Case Studies
Figure 10. Irritable Bowel Syndrome Case Studies
Figure 11. Peptic Ulcer Disease (PUD) Case Studies
Figure 12. Others Case Studies
Figure 13. Gastrointestinal Therapeutics and Diagnostics Report Years Considered
Figure 14. Global Gastrointestinal Therapeutics and Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Gastrointestinal Therapeutics and Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Region: 2024 VS 2031
Figure 17. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Players in 2024
Figure 18. Global Top Gastrointestinal Therapeutics and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Therapeutics and Diagnostics as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Gastrointestinal Therapeutics and Diagnostics Revenue in 2024
Figure 20. North America Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Gastrointestinal Therapeutics and Diagnostics Market Share by Country (2020-2031)
Figure 22. United States Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Gastrointestinal Therapeutics and Diagnostics Market Share by Country (2020-2031)
Figure 26. Germany Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Share by Region (2020-2031)
Figure 34. China Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Gastrointestinal Therapeutics and Diagnostics Market Share by Country (2020-2031)
Figure 42. Mexico Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Share by Country (2020-2031)
Figure 46. Turkey Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Gastrointestinal Therapeutics and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Abbott Laboratories Revenue Growth Rate in Gastrointestinal Therapeutics and Diagnostics Business (2020-2025)
Figure 50. AstraZeneca Revenue Growth Rate in Gastrointestinal Therapeutics and Diagnostics Business (2020-2025)
Figure 51. Eisai Revenue Growth Rate in Gastrointestinal Therapeutics and Diagnostics Business (2020-2025)
Figure 52. Johnson & Johnson Revenue Growth Rate in Gastrointestinal Therapeutics and Diagnostics Business (2020-2025)
Figure 53. Salix Pharmaceuticals Revenue Growth Rate in Gastrointestinal Therapeutics and Diagnostics Business (2020-2025)
Figure 54. Takeda Pharmaceutical Company Revenue Growth Rate in Gastrointestinal Therapeutics and Diagnostics Business (2020-2025)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies